# Tranexamic Acid Versus Misoprostol in Reducing Blood Loss in Cesarean Section in Primigravida

> **NCT04635007** · PHASE3 · COMPLETED · sponsor: **Cairo University** · enrollment: 200 (actual)

## Conditions studied

- Cesarean Section Complications
- Blood Loss, Surgical
- Misoprostol
- Tranexamic Acid

## Interventions

- **DRUG:** Tranexamic acid
- **DRUG:** Misoprostol 200mcg Tab

## Key facts

- **NCT ID:** NCT04635007
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2022-06-01
- **Final completion:** 2022-06-30
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2022-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04635007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04635007, "Tranexamic Acid Versus Misoprostol in Reducing Blood Loss in Cesarean Section in Primigravida". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04635007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*